Product Information for the User
Zolmitriptán Flas Qualigen 2.5 mg Bucodispersable Tablets EFG
Zolmitriptán
Read this entire product information carefully before starting to take the medication
Zolmitriptán Flas Qualigen belongs to a group of medicines called triptans.
Zolmitriptán Flas Qualigen is used to treat migraine headache
Do not take Zolmitriptán Flas Qualigen
If you are unsure whether any of this applies to you, consult your doctor or pharmacist.
Be especially careful with Zolmitriptán Flas Qualigen
Before starting treatment with Zolmitriptán Flas Qualigen, inform your doctor:
If you go to a hospital, you must inform your doctor or healthcare staff that you are taking Zolmitriptán Flas Qualigen.
Zolmitriptán Flas Qualigen is not recommended for people under 18 years or over 65 years.
Like other migraine treatments, excessive use of Zolmitriptán Flas Qualigen may cause daily headaches or worsening of your migraine headaches. Consult your doctor if you think this is the case. You may need to stop using Zolmitriptán Flas Qualigen to correct the problem.
Use of other medications
Inform your doctor or pharmacist if you are using or have recently used other medications. This includes herbal remedies and medications that you purchase without a prescription.
Especially inform your doctor if you are taking any of the following medications:
Migraine medications
Depression medications
Other medications
If you are using herbal preparations that contain St. John's Wort (Hypericum perforatum), you may increase the likelihood of adverse effects from Zolmitriptán Flas Qualigen
Taking Zolmitriptán Flas Qualigen with food and drinks
You can take Zolmitriptán Flas Qualigen with or without food. This does not affect how Zolmitriptán Flas Qualigen works.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medication.
The safety of taking Zolmitriptán Flas Qualigen during pregnancy is unknown. Inform your doctor if you are pregnant or trying to become pregnant.
Avoid breastfeeding for 24 hours after taking zolmitriptán.
Driving and operating machinery
This medication, like migraine, can cause drowsiness. If you experience these effects, avoid driving or operating machinery as it may be hazardous.
During a migraine crisis, your reactions may be slower than usual. Be aware of this when driving or using tools or machinery.
Important information about some of the components of Zolmitriptán Flas Qualigen
This medication contains 0.90 mg of aspartame in each tablet. Aspartame contains a source of phenylalanine that may be harmful in the case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Follow exactly the administration instructions for Zolmitriptán Flas Qualigen as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
You can take Zolmitriptán Flas Qualigen as soon as a migraine headache or migraine crisis begins. You can also take it once a crisis has started.
The usual dose is a tablet (2.5 mg).
If the tablets did not provide enough help for your migraine, inform your doctor. Your doctor may increase the dose to 5 mg or change your treatment. Do not use more than the dose prescribed.
Do not use more than two doses in a day. If you have been prescribed the 2.5 mg tablet, the maximum daily dose is 5 mg.
If you take more Zolmitriptán Flas Qualigen than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Like other migraine treatments, excessive use of Zolmitriptán Flas Qualigen can cause daily headaches or worsening of migraine headaches. Consult your doctor if you think this is your case. You may need to stop taking Zolmitriptán Flas Qualigen to correct the problem.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, Zolmitriptán Flas Qualigen can cause side effects, although not everyone will experience them.
Some of the side effects listed below may be symptoms of the migraine itself.
Frequent side effects (may affect between 1 and 10 in every 100 patients)
Less frequent side effects (may affect between 1 and 10 in every 1,000 patients)
Rare side effects (may affect between 1 and 10 in every 10,000 patients)
Very rare side effects (may affect fewer than 1 in every 10,000 patients)
If you consider any of the side effects you experience to be severe or if you notice any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
Do not use Zolmitriptán Flas Qualigen after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C. Store in the original packaging.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Zolmitriptán Flas Qualigen
The active ingredient is zolmitriptan. Each buccal dispersible tablet contains 2.5mg of active ingredient.
The other components are: mannitol (E-421), crospovidone, calcium silicate, aspartate (E-951), orange aroma (contains natural aroma and flavoring components, corn maltodextrin, and gum arabic), strawberry aroma (contains natural aroma and flavoring components, corn maltodextrin, triethyl citrate (E-1505), and propylene glycol (E-1520)), citric acid monohydrate (E-330), and magnesium stearate (E-470).
Appearance of Zolmitriptán Flas Qualigen and packaging contents
Zolmitriptán Flas Qualigen buccal dispersible tablets are white, flat-faced, and round.
Zolmitriptán Flas Qualigen is available in aluminum blister packs containing 2, 6, or 12 (6x2) buccal dispersible tablets.
Only some packaging sizes may be marketed.
Other presentations
Zolmitriptán Flas Qualigen 5mg buccal dispersible tablets: packaging of 2, 6, or 12 (6 x2) tablets.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona 69
08970 Sant Joan Despí
Barcelona – Spain
Responsible manufacturer
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona 69
08970 Sant Joan Despí
Barcelona – Spain
This leaflet was approved in September 2021
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/
The average price of Zolmitriptan flas qualigen 2,5 mg comprimidos bucodispersables efg in July, 2025 is around 16.08 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.